From Stem Cell to Red Blood Cells In Vitro: "The 12 Labors of Hercules"

Clinics in Laboratory Medicine

Volumn 30, Issue 2, 2010, Pages 391-403

  Douay, Luc ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Artificial blood; Hemoglobin; Stem cells; Transfusion medicine

Indexed keywords

ARTIFICIAL BLOOD; FLUOROCARBON; HEMOGLOBIN; HEMOGLOBIN A;

AUTOTRANSPLANTATION; BLOOD SUBSTITUTION; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CLINICAL PRACTICE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE COUNT; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; ERYTHROID CELL; ERYTHROPOIESIS; GOOD MANUFACTURING PRACTICE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HEMOGLOBIN ANALYSIS; HEMOGLOBIN SYNTHESIS; HUMAN; LARGE SCALE PRODUCTION; MEDICAL RESEARCH; MYELODYSPLASTIC SYNDROME; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RETICULOCYTE; REVIEW; SICKLE CELL ANEMIA; SOCIAL MARKETING; TREATMENT INDICATION;

ADULT; BLOOD GROUP ANTIGENS; BLOOD SUBSTITUTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HEMOGLOBINS; HUMANS; MARKETING OF HEALTH SERVICES; RETICULOCYTES;

EID: 77953334955     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.02.003     Document Type: Review

References (24)

1. Jc D. Population projections of the United States by age, sex, race and Hispanic origin: 1995 to 2050 1996, Current Population Reports, U.S. Bureau of the Census, Washington, DC, p. 25.
2. Robert-Bobée I. Projections de population pour la France métropolitaine à l'horizon 2050 2006, INSEE Première, Paris.
3. Group USCSW United States cancer statistics: 2002 incidence and mortality 2005, U.S. Department of Health and Human Services, Centers of Disease Control and Prevention and National Cancer Institute, Atlanta (GA).
4. Natanson C., Kern S.J., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008, 299:2304.
5. Douay L., Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?. Transfus Med Rev 2007, 21:91.
6. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993, 81:2844.
7. Lu L., Xiao M., Shen R.N., et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993, 81:41.
8. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974, 2:83.
9. Verfaillie C.M. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993, 82:2045.
10. Douay L. Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001, 10:341.
11. Neildez-Nguyen T.M., Wajcman H., Marden M.C., et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002, 20:467.
12. Giarratana M.C., Kobari L., Lapillonne H., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005, 23:69.
13. Miharada K., Hiroyama T., Sudo K., et al. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006, 24:1255.
14. Fujimi A., Matsunaga T., Kobune M., et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol 2008, 87:339.
15. Garderet L., Kobari L., Mazurier C.H., et al. A new single cell culture approach demonstrates absence of terminal erythroid differentiation alterations with preservation of enucleation capacity in myelodysplastic 5q(del) clones. Haematologica 2010, 95(3):398-405.
16. Bagnis C., Chapel S., Chiaroni J., et al. A genetic strategy to control expression of human blood group antigens in red blood cells generated in vitro. Transfusion 2009, 49:967.
17. Qiu C., Hanson E., Olivier E., et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005, 33:1450.
18. Lu S.J., Feng Q., Park J.S., et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008, 112:4475.
19. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663.
20. Migliaccio A.R., Whitsett C., Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol 2009, 16:259.
21. Timmins N.E., Nielsen L.K. Blood cell manufacture: current methods and future challenges. Trends Biotechnol 2009, 27:415.
22. Vlaski M., Lafarge X., Chevaleyre J., et al. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo. Exp Hematol 2009, 37:573.
23. McAdams T.A., Miller W.M., Papoutsakis E.T. pH is a potent modulator of erythroid differentiation. Br J Haematol 1998, 103:317.
24. Hanna J., Wernig M., Markoulaki S., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 1920, 318:2007.